In p53 WT high-risk GISTs, the p53 signaling pathway is often disrupted due to MDM2 overexpression, which impairs p53’s tumor-suppressive functions, leading to genomic instability, uncontrolled proliferation, and oncogene activation. Here, MDM2 is linked to neoplasm.